Literature DB >> 7239349

Studies on blood coagulation and fibrinolysis in pregnancy, during delivery and in the puerperium. I. Normal condition.

M Hellgren, M Blombäck.   

Abstract

Blood coagulation and fibrinolytic variables were investigated with recently developed laboratory methods during normal pregnancy, at delivery and during puerperium. The state of hypercoagulability was registered by an increase in activity of factors XII, X and VIII, in VIII antigen, in ratio between VIII antigen and activity as well as in fibrinogen. Activation of blood coagulation at delivery results in decreasing levels of factors XII and XI and an increase in fibrinopeptide A. However, normal mean values of antithrombin and platelets were observed. An increase is noted in the plasminogen level as well as in urokinase inhibitor during pregnancy. In addition alpha 2-antiplasmin and prekallikrein were studied; however, no marked changes were noted.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7239349     DOI: 10.1159/000299596

Source DB:  PubMed          Journal:  Gynecol Obstet Invest        ISSN: 0378-7346            Impact factor:   2.031


  15 in total

1.  Decrease in protein C inhibitor activity and acquired APC resistance during normal pregnancy.

Authors:  H Shu; M Wramsby; M Bokarewa; M Blombäck; K Bremme
Journal:  J Thromb Thrombolysis       Date:  2000-04       Impact factor: 2.300

2.  The cost-benefit ratio of screening pregnant women for thrombophilia.

Authors:  Gian Luca Salvagno; Giuseppe Lippi; Massimo Franchini; Giovanni Targher; Martina Montagnana; Massimo Franchi; Gian Cesare Guidi
Journal:  Blood Transfus       Date:  2007-11       Impact factor: 3.443

Review 3.  Perils, problems, and progress in laboratory diagnosis of von Willebrand disease.

Authors:  Veronica H Flood
Journal:  Semin Thromb Hemost       Date:  2013-12-12       Impact factor: 4.180

Review 4.  New insights into genotype and phenotype of VWD.

Authors:  Veronica H Flood
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2014-11-18

5.  Prevalence of coagulation abnormalities associated with intrauterine fetal death.

Authors:  A D Maslow; T W Breen; M C Sarna; A K Soni; J Watkins; N E Oriol
Journal:  Can J Anaesth       Date:  1996-12       Impact factor: 5.063

6.  The pattern and magnitude of "in vivo thrombin generation" differ in women with preeclampsia and in those with SGA fetuses without preeclampsia.

Authors:  Offer Erez; Roberto Romero; Edi Vaisbuch; Juan Pedro Kusanovic; Shali Mazaki-Tovi; Tinnakorn Chaiworapongsa; Francesca Gotsch; Pooja Mittal; Samuel S Edwin; Chia-Ling Nhan-Chang; Nandor Gabor Than; Chong Jai Kim; Sun Kwon Kim; Lami Yeo; Moshe Mazor; Sonia S Hassan
Journal:  J Matern Fetal Neonatal Med       Date:  2017-05-23

7.  The effect of low molecular weight heparin (dalteparin) on duration and initiation of labour.

Authors:  Nazim Isma; Peter J Svensson; Bengt Lindblad; Pelle G Lindqvist
Journal:  J Thromb Thrombolysis       Date:  2010-08       Impact factor: 2.300

8.  Functional investigation of a venous thromboembolism GWAS signal in a promoter region of coagulation factor XI gene.

Authors:  Minyoung Kong; Younyoung Kim; Chaeyoung Lee
Journal:  Mol Biol Rep       Date:  2014-01-14       Impact factor: 2.316

Review 9.  Pregnancy and cardiovascular disease.

Authors:  Karishma P Ramlakhan; Mark R Johnson; Jolien W Roos-Hesselink
Journal:  Nat Rev Cardiol       Date:  2020-06-09       Impact factor: 32.419

10.  Interaction between pregnancy zone protein and plasmin.

Authors:  O M Poulsen; J Hau
Journal:  Arch Gynecol Obstet       Date:  1988       Impact factor: 2.344

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.